Attending an industry event is one of the best things you can do for the future of your business, your career and your profession. The Pharmacy Show is the largest national conference and exhibition for community pharmacy professionals.
The event provides pharmacy owners and their teams unprecedented access to two days of CPD education and support, hands-on training, and up-skilling, and the opportunity to source the latest product and service innovations. With the government’s vision of a more clinically-focused workforce being overshadowed by funding cuts, The Pharmacy Show aims to guide the profession on how to successfully manage the changes required to run a profitable and efficient pharmacy, never losing sight of improving patient outcomes, bettering the health of the communities they serve, and ensuring a savvy retail business.
With over 400 exhibiting companies and eight comprehensive education streams, there is something for every member of the team.
New for 2017
Programmed by the Royal Pharmaceutical Society (RPS), the Career Development Zone will explore how pharmacists can stand out from the crowd and also learn about new roles that are developing in GP surgeries, care homes and urgent care. Topics will include professional standards in pharmacy; career and professional development and revalidation. There will also be a showcase of innovators in pharmacy. The programme has been developed in association with an advisory panel. Its members include RPS Assembly members.
Live Flu Training
This year the show will feature two companies running live flu and CPR training sessions. RX Advisor, who ran training at the show last year, and ECG Ltd will both be running discounted training workshops on both days.
Impressive speaker line-up
This year’s speakers will provide you with a wealth of usable content that will be beneficial to you, your team and your pharmacy. All the main professional bodies will be represented and include: Sue Sharpe, chief executive officer, PSNC; Andrew Evans, chief pharmaceutical officer, Wales; Duncan Rudkin, chief executive, General Pharmaceutical Council; Ash Soni, president, Royal Pharmaceutical Society; Matt Barclay, director of operations, Community Pharmacy Scotland; Anne Joshua, head of pharmacy strategy, NHS England; Cormac Tobin, managing director, Celesio UK; Leyla Hannbeck, chief pharmacist, NPA; Peter Blundell, Senior GDP Inspector, MHRA; Bharat Shah, managing director, Sigma Pharmaceuticals plc; James Kingsland, president, National Association for Primary Care; Mark Koziol, chairman, PDA and Ian Strachan, chair, NPA.